This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Apelon And MaestroDev Partner To Improve Healthcare Terminologies At VHA

RIDGEFIELD, Conn., Dec. 11, 2012 /PRNewswire/ -- Apelon, a provider of terminology and data interoperability solutions, and MaestroDev, a provider of DevOps Orchestration and software infrastructure automation, today announced they are working together to assist the U.S. Department of Veterans Affairs to improve healthcare data sharing and analysis. 

Apelon is providing products and consulting expertise in terminology and data standardization and MaestroDev is providing development and operations automation, including a platform on which to build, test and release software.  Together Apelon and Maestro are enabling expanded use by the Veterans Health Administration of the International Health Terminology Standards Development Organization (IHTSDO) Workbench, an important emergent open source terminology development tool.  The immediate work product of the collaboration will be a new terminology management environment for the VHA.

More specifically, Apelon and MaestroDev are configuring the Workbench to manage local, national, and international terminology standards across VA hospitals nationwide. The challenge of perfecting workflows to achieve requisite productivity and accuracy in a terminology project of this magnitude has been addressed by a synergistic integration of Apelon's terminology experience and MaestroDev's DevOps Orchestration engine.

"Maintaining a better, more standardized terminology environment for the VHA will improve the exchange and analysis of veterans' health information," said Stephen Coady, Apelon's CEO. "We are honored to be entrusted with this work and grateful for previous engagements from several agencies that readied the underpinning of this project."

"Our previous Workbench projects including Kaiser Permanente, the Australian National eHealth Transition Authority and IHTSDO perfectly position us to work with Apelon and the U.S. Department of Veterans Affairs," said Doug Dennington, MaestroDev CEO.  "Automating best practices from DevOps and agile methodologies to provide Continuous Delivery of the Workbench software means that the VHA can improve its internal terminology standardization and interact more effectively with its community partners. That translates to better, more efficient care for veterans."

About Apelon

Apelon, Inc. is a longstanding international clinical informatics company focusing on data standardization and interoperability. Apelon software and professional services help leading healthcare enterprises, life sciences organizations and government agencies improve the quality, comparability and accessibility of their information. Visit  www.Apelon.com for additional information.

About MaestroDev

MaestroDev provides DevOps Orchestration and best practices for enterprise-scale development organizations across a range of industries. A single interface automates task management for Continuous Delivery, Agile development, DevOps, and Cloud Federation. Fortune 500 companies rely on MaestroDev to deliver business-critical applications with more frequency, consistency, and faster time to market.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,065.37 -56.64 -0.33%
S&P 500 1,995.47 -4.65 -0.23%
NASDAQ 4,558.4240 -11.1970 -0.24%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs